Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells.
about
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2HIPK2 is a new drug target for anti-fibrosis therapy in kidney diseaseProtection against ovariectomy-induced bone loss by tranilast.Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.Effective treatment for prevention of post-operative adhesion after strabismus surgery in experimental rabbit model: 0.5 % tranilast ophthalmic solution.Evaluation of the Combination of Methylprednisolone and Tranilast after Spinal Cord Injury in Rat Models.The role of transforming growth factor β in glaucoma and the therapeutic implications.Useful strategies to prevent severe stricture after endoscopic submucosal dissection for superficial esophageal neoplasmThe Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX.The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice.Inhibitory Effects of Tranilast on Cytokine, Chemokine, Adhesion Molecule, and Matrix Metalloproteinase Expression in Human Corneal Fibroblasts Exposed to Poly(I:C).Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest.Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
P2860
Q24642280-D9A64740-16A8-4979-8351-66B956E5E84EQ26996407-2FA41402-1B3E-4D53-A1E5-FDC7CBEA96D0Q35154009-66A5AD76-D84E-4F29-8FB7-98097521AA49Q35927429-9C8CBCBB-CDCC-4E5D-917C-63C36F393B47Q36139952-42F7016A-B007-4953-82B4-6D6ED35B7FFEQ37112548-90122FA6-BF21-48E7-A041-97DEC746B5A1Q38074418-532A29D0-C6B9-484D-B52B-1BFABABDE96CQ38537513-1388D7A6-7535-4226-840E-F5C055E6BF5BQ38879058-F343663C-AB8A-476B-99D4-4D6A25E5EDD3Q39253354-891FB301-F99C-42F2-8846-19131A6513B3Q40699017-DEB67FB6-02DF-4882-8F93-E3217C6A3C6CQ46526307-1CBD332D-D4AA-4C94-8C86-DCC3ACF31802Q52659646-EBE1BC97-4204-456F-89ED-C0FC8233C660Q58711702-87FBD6A9-9CCE-49B6-A284-C7B0B7B56A08
P2860
Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@ast
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@en
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@nl
type
label
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@ast
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@en
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@nl
prefLabel
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@ast
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@en
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@nl
P2093
P356
P1476
Tranilast inhibits cytokine-in ...... in vascular endothelial cells.
@en
P2093
Harald Darius
Ioana Lorenz
Martin Spiecker
Nikolaus Marx
P304
P356
10.1124/MOL.62.4.856
P577
2002-10-01T00:00:00Z